ADME–Tox in drug discovery: integration of experimental and computational technologies
- 2 September 2003
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 8 (18) , 852-861
- https://doi.org/10.1016/s1359-6446(03)02828-9
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- The Role of Absorption, Distribution, Metabolism, Excretion and Toxicity in Drug DiscoveryCurrent Topics in Medicinal Chemistry, 2003
- Comparative study of the metabolism of drug substrates by human cytochrome P450 3A4 expressed in bacterial, yeast and human lymphoblastoid cellsXenobiotica, 2002
- In vitro preclinical lead optimisation technologies (PLOTs) in pharmaceutical developmentToxicology Letters, 2001
- Optimization of metabolic stability as a goal of modern drug designMedicinal Research Reviews, 2001
- Risks in new drug development: Approval success rates for investigational drugsClinical Pharmacology & Therapeutics, 2001
- Comparative Studies on in Vitro Methods for Evaluating in Vivo Function of MDR1 P-GlycoproteinPharmaceutical Research, 2001
- ADME/PK as part of a rational approach to drug discoveryDrug Discovery Today, 2000
- Pharmacokinetics and metabolism in early drug discoveryCurrent Opinion in Chemical Biology, 1999
- High-throughput approaches for evaluating absorption, distribution, metabolism and excretion properties of lead compoundsCurrent Opinion in Chemical Biology, 1998
- Managing the drug discovery/development interfaceDrug Discovery Today, 1997